type here...

CATEGORIES

Medication

LATEST

1234Page 2 of 4

TRENDING

EDITORS CHOICE

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Christopher Nial -
While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD -
The psychological effects of public space shootings extend beyond physical harm because they create a broad psychological impact on everyone present at the scene....

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories